Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 250

1.

Phenylketonuria Diet Promotes Shifts in Firmicutes Populations.

Bassanini G, Ceccarani C, Borgo F, Severgnini M, Rovelli V, Morace G, Verduci E, Borghi E.

Front Cell Infect Microbiol. 2019 Apr 16;9:101. doi: 10.3389/fcimb.2019.00101. eCollection 2019.

2.

Repurposing Pilocarpine Hydrochloride for Treatment of Candida albicans Infections.

Nile C, Falleni M, Cirasola D, Alghamdi A, Anderson OF, Delaney C, Ramage G, Ottaviano E, Tosi D, Bulfamante G, Morace G, Borghi E.

mSphere. 2019 Jan 23;4(1). pii: e00689-18. doi: 10.1128/mSphere.00689-18.

3.

Up-Regulation of Antimicrobial Peptides Gallerimycin and Galiomicin in Galleria mellonella Infected with Candida Yeasts Displaying Different Virulence Traits.

Dekkerová-Chupáčová J, Borghi E, Morace G, Bujdáková H.

Mycopathologia. 2018 Dec;183(6):935-940. doi: 10.1007/s11046-018-0300-7. Epub 2018 Nov 1.

PMID:
30386966
4.

Antenatal Microbial Colonization of Mammalian Gut.

Borghi E, Massa V, Severgnini M, Fazio G, Avagliano L, Menegola E, Bulfamante GP, Morace G, Borgo F.

Reprod Sci. 2019 Aug;26(8):1045-1053. doi: 10.1177/1933719118804411. Epub 2018 Oct 11.

5.

Phenylketonuric diet negatively impacts on butyrate production.

Verduci E, Moretti F, Bassanini G, Banderali G, Rovelli V, Casiraghi MC, Morace G, Borgo F, Borghi E.

Nutr Metab Cardiovasc Dis. 2018 Apr;28(4):385-392. doi: 10.1016/j.numecd.2018.01.004. Epub 2018 Jan 31.

PMID:
29502926
6.

Body Mass Index and Sex Affect Diverse Microbial Niches within the Gut.

Borgo F, Garbossa S, Riva A, Severgnini M, Luigiano C, Benetti A, Pontiroli AE, Morace G, Borghi E.

Front Microbiol. 2018 Feb 14;9:213. doi: 10.3389/fmicb.2018.00213. eCollection 2018.

7.

Anti-biofilm activity of antibody directed against surface antigen complement receptor 3-related protein-comparison of Candida albicans and Candida dubliniensis.

Chupácová J, Borghi E, Morace G, Los A, Bujdáková H.

Pathog Dis. 2018 Feb 1;76(1). doi: 10.1093/femspd/ftx127.

PMID:
29315379
8.

Microbiota in anorexia nervosa: The triangle between bacterial species, metabolites and psychological tests.

Borgo F, Riva A, Benetti A, Casiraghi MC, Bertelli S, Garbossa S, Anselmetti S, Scarone S, Pontiroli AE, Morace G, Borghi E.

PLoS One. 2017 Jun 21;12(6):e0179739. doi: 10.1371/journal.pone.0179739. eCollection 2017.

9.

A rare case of subcutaneous fusariosis in an immunocompetent patient.

Mapelli ET, Cerri A, Borghi E, Palvarini M, Abramo P, Morace G, Menni S.

G Ital Dermatol Venereol. 2017 Apr;152(2):178-180. doi: 10.23736/S0392-0488.16.04787-8.

PMID:
28166614
10.

A Naturally Occurring Antibody Fragment Neutralizes Infectivity of Diverse Infectious Agents.

Polonelli L, Ciociola T, Elviri L, Zanello PP, Giovati L, Arruda DC, Muñoz JE, Mortara RA, Morace G, Borghi E, Galati S, Marin O, Casoli C, Pilotti E, Ronzi P, Travassos LR, Magliani W, Conti S.

Sci Rep. 2016 Oct 11;6:35018. doi: 10.1038/srep35018.

11.

Pediatric obesity is associated with an altered gut microbiota and discordant shifts in Firmicutes populations.

Riva A, Borgo F, Lassandro C, Verduci E, Morace G, Borghi E, Berry D.

Environ Microbiol. 2017 Jan;19(1):95-105. doi: 10.1111/1462-2920.13463. Epub 2016 Aug 22.

12.

Fungal Biofilms: Update on Resistance.

Borghi E, Borgo F, Morace G.

Adv Exp Med Biol. 2016;931:37-47. doi: 10.1007/5584_2016_7. Review.

PMID:
27115411
13.

Relative Abundance in Bacterial and Fungal Gut Microbes in Obese Children: A Case Control Study.

Borgo F, Verduci E, Riva A, Lassandro C, Riva E, Morace G, Borghi E.

Child Obes. 2017 Feb;13(1):78-84. doi: 10.1089/chi.2015.0194. Epub 2016 Mar 23.

PMID:
27007700
14.

Molecular Identification and Echinocandin Susceptibility of Candida parapsilosis Complex Bloodstream Isolates in Italy, 2007-2014.

Lovero G, Borghi E, Balbino S, Cirasola D, De Giglio O, Perdoni F, Caggiano G, Morace G, Montagna MT.

PLoS One. 2016 Feb 26;11(2):e0150218. doi: 10.1371/journal.pone.0150218. eCollection 2016.

15.

Antifungal activity of Myriocin on clinically relevant Aspergillus fumigatus strains producing biofilm.

Perdoni F, Signorelli P, Cirasola D, Caretti A, Galimberti V, Biggiogera M, Gasco P, Musicanti C, Morace G, Borghi E.

BMC Microbiol. 2015 Oct 30;15:248. doi: 10.1186/s12866-015-0588-0.

16.

New strategic insights into managing fungal biofilms.

Borghi E, Morace G, Borgo F, Rajendran R, Sherry L, Nile C, Ramage G.

Front Microbiol. 2015 Oct 6;6:1077. doi: 10.3389/fmicb.2015.01077. eCollection 2015.

17.

Methicillin-Resistant Staphylococcus aureus in Raw Milk: Prevalence, SCCmec Typing, Enterotoxin Characterization, and Antimicrobial Resistance Patterns.

Riva A, Borghi E, Cirasola D, Colmegna S, Borgo F, Amato E, Pontello MM, Morace G.

J Food Prot. 2015 Jun;78(6):1142-6. doi: 10.4315/0362-028X.JFP-14-531.

18.

Detection of Pneumocystis jirovecii and Aspergillus spp. DNa in bronchoalveolar lavage fluids by commercial real-time PCr assays: comparison with conventional diagnostic tests.

Orsi CF, Bettua C, Pini P, Venturelli C, La Regina A, Morace G, Luppi M, Forghieri F, Bigliardi S, Luppi F, Codeluppi M, Girardis M, Blasi E.

New Microbiol. 2015 Jan;38(1):75-84. Epub 2015 Jan 1.

19.

Inhibitory effects of different lactobacilli on Candida albicans hyphal formation and biofilm development.

Orsi CF, Sabia C, Ardizzoni A, Colombari B, Neglia RG, Peppoloni S, Morace G, Blasi E.

J Biol Regul Homeost Agents. 2014 Oct-Dec;28(4):743-52.

PMID:
25620183
20.

Antifungal drug resistance in Candida species.

Morace G, Perdoni F, Borghi E.

J Glob Antimicrob Resist. 2014 Dec;2(4):254-259. doi: 10.1016/j.jgar.2014.09.002. Epub 2014 Sep 28. Review.

PMID:
27873684
21.

How to manage aspergillosis in non-neutropenic intensive care unit patients.

Bassetti M, Righi E, De Pascale G, De Gaudio R, Giarratano A, Mazzei T, Morace G, Petrosillo N, Stefani S, Antonelli M.

Crit Care. 2014 Jul 25;18(4):458. doi: 10.1186/s13054-014-0458-4. Review.

22.

Impact of Candida albicans hyphal wall protein 1 (HWP1) genotype on biofilm production and fungal susceptibility to microglial cells.

Orsi CF, Borghi E, Colombari B, Neglia RG, Quaglino D, Ardizzoni A, Morace G, Blasi E.

Microb Pathog. 2014 Apr-May;69-70:20-7. doi: 10.1016/j.micpath.2014.03.003. Epub 2014 Mar 28.

PMID:
24685698
23.

Candidemia in intensive care unit: a nationwide prospective observational survey (GISIA-3 study) and review of the European literature from 2000 through 2013.

Montagna MT, Lovero G, Borghi E, Amato G, Andreoni S, Campion L, Lo Cascio G, Lombardi G, Luzzaro F, Manso E, Mussap M, Pecile P, Perin S, Tangorra E, Tronci M, Iatta R, Morace G.

Eur Rev Med Pharmacol Sci. 2014;18(5):661-74. Review.

24.

Correlation between Candida albicans biofilm formation and invasion of the invertebrate host Galleria mellonella.

Borghi E, Romagnoli S, Fuchs BB, Cirasola D, Perdoni F, Tosi D, Braidotti P, Bulfamante G, Morace G, Mylonakis E.

Future Microbiol. 2014;9(2):163-73. doi: 10.2217/fmb.13.159.

PMID:
24571071
25.

Human pathogenic viruses are retained in and released by Candida albicans biofilm in vitro.

Mazaheritehrani E, Sala A, Orsi CF, Neglia RG, Morace G, Blasi E, Cermelli C.

Virus Res. 2014 Jan 22;179:153-60. doi: 10.1016/j.virusres.2013.10.018. Epub 2013 Oct 30.

PMID:
24184317
26.

Antifungal resistance does not necessarily affect Candida glabrata fitness.

Borghi E, Andreoni S, Cirasola D, Ricucci V, Sciota R, Morace G.

J Chemother. 2014 Feb;26(1):32-6. doi: 10.1179/1973947813Y.0000000100. Epub 2013 Dec 6.

PMID:
24091025
27.

Experimental biofilm-related Candida infections.

Cirasola D, Sciota R, Vizzini L, Ricucci V, Morace G, Borghi E.

Future Microbiol. 2013 Jun;8(6):799-805. doi: 10.2217/fmb.13.36.

PMID:
23701334
28.

A survey on infection management practices in Italian ICUs.

Bassetti M, De Gaudio R, Mazzei T, Morace G, Petrosillo N, Viale P, Bello G, La Face S, Antonelli M.

Crit Care. 2012 Nov 15;16(6):R221. doi: 10.1186/cc11866.

29.

Invasive mold infections: virulence and pathogenesis of mucorales.

Morace G, Borghi E.

Int J Microbiol. 2012;2012:349278. doi: 10.1155/2012/349278. Epub 2011 Nov 1.

30.

Tinea corporis due to Trichophyton rubrum in a woman and Tinea capitis in her 15-day-old baby: molecular evidence of vertical transmission.

Mapelli ET, Borghi E, Cerri A, Sciota R, Morace G, Menni S.

Mycopathologia. 2012 Mar;173(2-3):135-8. doi: 10.1007/s11046-011-9492-9. Epub 2011 Oct 14.

PMID:
21997860
31.

Antifungal susceptibility of invasive yeast isolates in Italy: the GISIA3 study in critically ill patients.

Morace G, Borghi E, Iatta R, Amato G, Andreoni S, Brigante G, Farina C, Lo Cascio G, Lombardi G, Manso E, Mussap M, Pecile P, Rigoli R, Tangorra E, Valmarin M, Montagna MT.

BMC Infect Dis. 2011 May 17;11:130. doi: 10.1186/1471-2334-11-130.

32.

Synthesis and in vitro antimicrobial activities of new (cyano-NNO-azoxy)pyrazole derivatives.

Boschi D, Guglielmo S, Aiello S, Morace G, Borghi E, Fruttero R.

Bioorg Med Chem Lett. 2011 Jun 1;21(11):3431-4. doi: 10.1016/j.bmcl.2011.03.101. Epub 2011 Apr 5.

33.

Characterization of Candida parapsilosis complex strains isolated from invasive fungal infections.

Borghi E, Sciota R, Iatta R, Biassoni C, Montagna MT, Morace G.

Eur J Clin Microbiol Infect Dis. 2011 Nov;30(11):1437-41. doi: 10.1007/s10096-011-1242-x. Epub 2011 Apr 10.

PMID:
21479840
34.

Surface localization of glucosylceramide during Cryptococcus neoformans infection allows targeting as a potential antifungal.

Rhome R, Singh A, Kechichian T, Drago M, Morace G, Luberto C, Del Poeta M.

PLoS One. 2011 Jan 21;6(1):e15572. doi: 10.1371/journal.pone.0015572.

35.

Cell surface hydrophobicity: a predictor of biofilm production in Candida isolates?

Borghi E, Sciota R, Biassoni C, Cirasola D, Cappelletti L, Vizzini L, Boracchi P, Morace G.

J Med Microbiol. 2011 May;60(Pt 5):689-90. doi: 10.1099/jmm.0.026898-0. Epub 2011 Jan 27. No abstract available.

PMID:
21273372
36.

Fungal infections in ICU patients: epidemiology and the role of diagnostics.

Morace G, Borghi E.

Minerva Anestesiol. 2010 Nov;76(11):950-6. Review.

37.

Chronic airway colonization by Scedosporium apiospermum with a fatal outcome in a patient with cystic fibrosis.

Borghi E, Iatta R, Manca A, Montagna MT, Morace G.

Med Mycol. 2010 Nov;48 Suppl 1:S108-13. doi: 10.3109/13693786.2010.504239.

PMID:
21067322
38.

Molecular picture of community- and healthcare-associated methicillin-resistant Staphylococcus aureus circulating in a teaching hospital in Milan.

Borghi E, Cainarca M, Sciota R, Biassoni C, Morace G.

Scand J Infect Dis. 2010 Dec;42(11-12):873-8. doi: 10.3109/00365548.2010.508465. Epub 2010 Aug 25.

PMID:
20735332
39.

Comparative evaluation of the Vitek 2 yeast susceptibility test and CLSI broth microdilution reference method for testing antifungal susceptibility of invasive fungal isolates in Italy: the GISIA3 study.

Borghi E, Iatta R, Sciota R, Biassoni C, Cuna T, Montagna MT, Morace G.

J Clin Microbiol. 2010 Sep;48(9):3153-7. doi: 10.1128/JCM.00952-10. Epub 2010 Jul 14.

40.

Anidulafungin, a new echinocandin: in vitro activity.

Morace G, Borghi E, Iatta R, Montagna MT.

Drugs. 2009;69 Suppl 1:91-4. doi: 10.2165/11315560-000000000-00000. Review.

PMID:
19877740
41.

The role of the laboratory in the diagnosis of invasive candidiasis.

Montagna MT, Caggiano G, Borghi E, Morace G.

Drugs. 2009;69 Suppl 1:59-63. doi: 10.2165/11315630-000000000-00000. Review.

PMID:
19877736
42.

Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology).

Pagano L, Valentini CG, Posteraro B, Girmenia C, Ossi C, Pan A, Candoni A, Nosari A, Riva M, Cattaneo C, Rossini F, Fianchi L, Caira M, Sanguinetti M, Gesu GP, Lombardi G, Vianelli N, Stanzani M, Mirone E, Pinsi G, Facchetti F, Manca N, Savi L, Mettimano M, Selva V, Caserta I, Scarpellini P, Morace G, D'Arminio Monforte A, Grossi P, Giudici D, Tortorano AM, Bonini A, Ricci L, Picardi M, Rossano F, Fanci R, Pecile P, Fumagalli L, Ferrari L, Capecchi PL, Romano C, Busca A, Barbui A, Garzia M, Minniti RR, Farina G, Montagna MT, Bruno F, Morelli O, Chierichini A, Placanica PM, Castagnola E, Bandettini R, Giordano S, Monastero R, Tosti ME, Rossi MR, Spedini P, Piane R, Nucci M, Pallavicini F, Bassetti M, Cristini F, LA Sorda M, Viviani M.

J Chemother. 2009 Jun;21(3):322-9.

PMID:
19567354
43.

The ABC transporter-encoding gene AFR1 affects the resistance of Cryptococcus neoformans to microglia-mediated antifungal activity by delaying phagosomal maturation.

Orsi CF, Colombari B, Ardizzoni A, Peppoloni S, Neglia R, Posteraro B, Morace G, Fadda G, Blasi E.

FEMS Yeast Res. 2009 Mar;9(2):301-10. doi: 10.1111/j.1567-1364.2008.00470.x.

44.

Evaluation of the virucidal activity of chemical disinfectants and antiseptics: the European point of view.

Morace G, Bellamy K, Maris P, Steinmann J.

Infect Control Hosp Epidemiol. 2009 Mar;30(3):301-2; author reply 302-4. doi: 10.1086/595980. No abstract available.

PMID:
19215196
45.

App1: an antiphagocytic protein that binds to complement receptors 3 and 2.

Stano P, Williams V, Villani M, Cymbalyuk ES, Qureshi A, Huang Y, Morace G, Luberto C, Tomlinson S, Del Poeta M.

J Immunol. 2009 Jan 1;182(1):84-91.

46.

Rhodococcus equi infection in a patient with spinocellular carcinoma of unknown origin.

Borghi E, La Francesca M, Gazzola L, Marchetti G, Zonato S, Foa P, d'Arminio Monforte A, Morace G.

J Med Microbiol. 2008 Nov;57(Pt 11):1431-3. doi: 10.1099/jmm.0.2008/002048-0.

PMID:
18927425
47.

The unique role of domain 2A of the hepatitis A virus precursor polypeptide P1-2A in viral morphogenesis.

Morace G, Kusov Y, Dzagurov G, Beneduce F, Gauss-Muller V.

BMB Rep. 2008 Sep 30;41(9):678-83.

48.

Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy.

Marchetti G, Bellistrì GM, Borghi E, Tincati C, Ferramosca S, La Francesca M, Morace G, Gori A, Monforte AD.

AIDS. 2008 Oct 1;22(15):2035-8. doi: 10.1097/QAD.0b013e3283112d29.

PMID:
18784466
49.

Clotrimazole scaffold as an innovative pharmacophore towards potent antimalarial agents: design, synthesis, and biological and structure-activity relationship studies.

Gemma S, Campiani G, Butini S, Kukreja G, Coccone SS, Joshi BP, Persico M, Nacci V, Fiorini I, Novellino E, Fattorusso E, Taglialatela-Scafati O, Savini L, Taramelli D, Basilico N, Parapini S, Morace G, Yardley V, Croft S, Coletta M, Marini S, Fattorusso C.

J Med Chem. 2008 Mar 13;51(5):1278-94. doi: 10.1021/jm701247k. Epub 2008 Feb 16.

PMID:
18278860
50.

In vitro activity (MIC and MFC) of voriconazole, amphotericin B, and itraconazole against 192 filamentous fungi: the GISIA-2 study.

Morace G, Drago M, Scaltrito MM, Conti S, Fanti F, Polonelli L; GISIA Participants Group.

J Chemother. 2007 Oct;19(5):508-13.

PMID:
18073149

Supplemental Content

Loading ...
Support Center